Clinical Trial Supply & Logistics Market Research Report by Services, Type, Phase, Therapeutic Area, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Clinical Trial Supply & Logistics Market Research Report by Services, Type, Phase, Therapeutic Area, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

The Global Clinical Trial Supply & Logistics Market size was estimated at USD 20.98 billion in 2021 and expected to reach USD 22.59 billion in 2022, and is projected to grow at a CAGR 7.69% to reach USD 32.74 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Clinical Trial Supply & Logistics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Services, the market was studied across Comparator Sourcing, Logistics & Distribution, Manufacturing, Packaging, Labeling, & Blinding, and Storage & Retention. The Logistics & Distribution is further studied across Cold Chain Distribution and Non-Cold Chain Distribution.

Based on Type, the market was studied across Biologic Drugs, Medical Devices, and Small Molecules.

Based on Phase, the market was studied across BA/ BE studies, Phase 1, Phase 2, Phase 3, and Phase 4.

Based on Therapeutic Area, the market was studied across Blood Disorders, Cardiovascular Diseases, CNS & Mental Disorders, Dermatological Disorders, Digestive Disorders, ENT Diseases, Immunology, Infectious Diseases, Metabolic Disorders, Nephrology, Oncology, Rare Diseases, and Respiratory Disorders.

Based on End User, the market was studied across Contract Research Organisations (CROs), Medical Devices Companies, and Pharmaceutical & Biotechnology companies.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across Arizona, California, Florida, Illinois, New York, North Carolina, Ohio, Oregon, Pennsylvania, Tennessee, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Clinical Trial Supply & Logistics market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trial Supply & Logistics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Trial Supply & Logistics Market, including Almac Group, Ancillare, LP, Biocair International Limited, Catalent, Inc., Clinigen Group PLC, Eurofins Scientific Group, ICON PLC, Infosys Limited, KLIFO A/S, Liveo Research GmbH, Lonza Group AG, Marken Limited, Myonex, Inc., N-SIDE SA, Parexel International Corporation, PCI Pharma Services, Piramal Pharma Solutions, SIRO Clinpharm Private Limited, Thermo Fisher Scientific, Inc., UDG Healthcare PLC, and Walden.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Clinical Trial Supply & Logistics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trial Supply & Logistics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trial Supply & Logistics Market?
4. What is the competitive strategic window for opportunities in the Global Clinical Trial Supply & Logistics Market?
5. What are the technology trends and regulatory frameworks in the Global Clinical Trial Supply & Logistics Market?
6. What is the market share of the leading vendors in the Global Clinical Trial Supply & Logistics Market?
7. What modes and strategic moves are considered suitable for entering the Global Clinical Trial Supply & Logistics Market?

Please Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Incidence of Chronic Diseases Globally
5.1.1.2. Rising Government Funds to R&D Activities
5.1.1.3. Globalization of Clinical Trials and Harmonization of Regulations
5.1.2. Restraints
5.1.2.1. High Cost Associated With the Clinical Trials
5.1.3. Opportunities
5.1.3.1. Rising Focus on Drug Development with the Launch of New Drugs
5.1.3.2. Outsourcing of Clinical Trial Activity
5.1.4. Challenges
5.1.4.1. Lack of Skilled Person to Operate Devices During Clinical Trials
5.2. Cumulative Impact of COVID-19
6. Clinical Trial Supply & Logistics Market, by Services
6.1. Introduction
6.2. Comparator Sourcing
6.3. Logistics & Distribution
6.4.1. Cold Chain Distribution
6.4.2. Non-Cold Chain Distribution
6.4. Manufacturing
6.5. Packaging, Labeling, & Blinding
6.6. Storage & Retention
7. Clinical Trial Supply & Logistics Market, by Type
7.1. Introduction
7.2. Biologic Drugs
7.3. Medical Devices
7.4. Small Molecules
8. Clinical Trial Supply & Logistics Market, by Phase
8.1. Introduction
8.2. BA/ BE studies
8.3. Phase 1
8.4. Phase 2
8.5. Phase 3
8.6. Phase 4
9. Clinical Trial Supply & Logistics Market, by Therapeutic Area
9.1. Introduction
9.2. Blood Disorders
9.3. Cardiovascular Diseases
9.4. CNS & Mental Disorders
9.5. Dermatological Disorders
9.6. Digestive Disorders
9.7. ENT Diseases
9.8. Immunology
9.9. Infectious Diseases
9.10. Metabolic Disorders
9.11. Nephrology
9.12. Oncology
9.13. Rare Diseases
9.14. Respiratory Disorders
10. Clinical Trial Supply & Logistics Market, by End User
10.1. Introduction
10.2. Contract Research Organisations (CROs)
10.3. Medical Devices Companies
10.4. Pharmaceutical & Biotechnology companies
11. Americas Clinical Trial Supply & Logistics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Clinical Trial Supply & Logistics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Clinical Trial Supply & Logistics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Almac Group
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Ancillare, LP
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Biocair International Limited
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Catalent, Inc.
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Clinigen Group PLC
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Eurofins Scientific Group
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. ICON PLC
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Infosys Limited
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. KLIFO A/S
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Liveo Research GmbH
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Lonza Group AG
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Marken Limited
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Myonex, Inc.
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. N-SIDE SA
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Parexel International Corporation
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. PCI Pharma Services
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Piramal Pharma Solutions
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. SIRO Clinpharm Private Limited
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Thermo Fisher Scientific, Inc.
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. UDG Healthcare PLC
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
15.21. Walden
15.21.1. Business Overview
15.21.2. Key Executives
15.21.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET DYNAMICS
FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2021 VS 2027 (%)
FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY SERVICES, 2027
FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COMPARATOR SOURCING, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COLD CHAIN DISTRIBUTION, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MANUFACTURING, 2018-2027 (USD MILLION)
FIGURE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STORAGE & RETENTION, 2018-2027 (USD MILLION)
FIGURE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2027
FIGURE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BIOLOGIC DRUGS, 2018-2027 (USD MILLION)
FIGURE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2027 (USD MILLION)
FIGURE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SMALL MOLECULES, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2021 VS 2027 (%)
FIGURE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY PHASE, 2027
FIGURE 30. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BA/ BE STUDIES, 2018-2027 (USD MILLION)
FIGURE 31. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 1, 2018-2027 (USD MILLION)
FIGURE 32. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 2, 2018-2027 (USD MILLION)
FIGURE 33. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 3, 2018-2027 (USD MILLION)
FIGURE 34. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 4, 2018-2027 (USD MILLION)
FIGURE 35. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2021 VS 2027 (%)
FIGURE 36. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2021 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY THERAPEUTIC AREA, 2027
FIGURE 38. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BLOOD DISORDERS, 2018-2027 (USD MILLION)
FIGURE 39. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2027 (USD MILLION)
FIGURE 40. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CNS & MENTAL DISORDERS, 2018-2027 (USD MILLION)
FIGURE 41. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DERMATOLOGICAL DISORDERS, 2018-2027 (USD MILLION)
FIGURE 42. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DIGESTIVE DISORDERS, 2018-2027 (USD MILLION)
FIGURE 43. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ENT DISEASES, 2018-2027 (USD MILLION)
FIGURE 44. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY IMMUNOLOGY, 2018-2027 (USD MILLION)
FIGURE 45. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2027 (USD MILLION)
FIGURE 46. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2027 (USD MILLION)
FIGURE 47. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NEPHROLOGY, 2018-2027 (USD MILLION)
FIGURE 48. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD MILLION)
FIGURE 49. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RARE DISEASES, 2018-2027 (USD MILLION)
FIGURE 50. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2027 (USD MILLION)
FIGURE 51. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 52. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 53. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2027
FIGURE 54. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS (CROS), 2018-2027 (USD MILLION)
FIGURE 55. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, 2018-2027 (USD MILLION)
FIGURE 56. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2027 (USD MILLION)
FIGURE 57. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 59. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 60. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 61. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 67. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 68. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 69. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 71. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 72. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 73. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 84. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 85. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 86. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 87. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 88. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 89. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 90. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 91. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 92. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 93. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 94. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 95. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 96. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 97. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 98. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 99. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 100. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 101. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 102. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 103. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 104. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 105. SWEDEN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 106. SWITZERLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 107. TURKEY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 108. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 109. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 110. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 111. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 112. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2021
TABLE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COMPARATOR SOURCING, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COMPARATOR SOURCING, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COMPARATOR SOURCING, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COLD CHAIN DISTRIBUTION, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COLD CHAIN DISTRIBUTION, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COLD CHAIN DISTRIBUTION, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MANUFACTURING, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, BY REGION, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STORAGE & RETENTION, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STORAGE & RETENTION, BY REGION, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STORAGE & RETENTION, BY REGION, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BIOLOGIC DRUGS, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2027 (USD MILLION)
TABLE 33. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2027 (USD MILLION)
TABLE 35. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SMALL MOLECULES, 2018-2027 (USD MILLION)
TABLE 36. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2027 (USD MILLION)
TABLE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2027 (USD MILLION)
TABLE 38. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
TABLE 39. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BA/ BE STUDIES, 2018-2027 (USD MILLION)
TABLE 40. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BA/ BE STUDIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 41. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BA/ BE STUDIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 42. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 1, 2018-2027 (USD MILLION)
TABLE 43. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 1, BY REGION, 2018-2027 (USD MILLION)
TABLE 44. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 1, BY REGION, 2018-2027 (USD MILLION)
TABLE 45. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 2, 2018-2027 (USD MILLION)
TABLE 46. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 2, BY REGION, 2018-2027 (USD MILLION)
TABLE 47. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 2, BY REGION, 2018-2027 (USD MILLION)
TABLE 48. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 3, 2018-2027 (USD MILLION)
TABLE 49. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 3, BY REGION, 2018-2027 (USD MILLION)
TABLE 50. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 3, BY REGION, 2018-2027 (USD MILLION)
TABLE 51. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 4, 2018-2027 (USD MILLION)
TABLE 52. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 4, BY REGION, 2018-2027 (USD MILLION)
TABLE 53. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 4, BY REGION, 2018-2027 (USD MILLION)
TABLE 54. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2027 (USD MILLION)
TABLE 55. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BLOOD DISORDERS, 2018-2027 (USD MILLION)
TABLE 56. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 57. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 58. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2027 (USD MILLION)
TABLE 59. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 60. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 61. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CNS & MENTAL DISORDERS, 2018-2027 (USD MILLION)
TABLE 62. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 63. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 64. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DERMATOLOGICAL DISORDERS, 2018-2027 (USD MILLION)
TABLE 65. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 66. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 67. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DIGESTIVE DISORDERS, 2018-2027 (USD MILLION)
TABLE 68. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 69. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 70. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ENT DISEASES, 2018-2027 (USD MILLION)
TABLE 71. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ENT DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 72. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ENT DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 73. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY IMMUNOLOGY, 2018-2027 (USD MILLION)
TABLE 74. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2027 (USD MILLION)
TABLE 75. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2027 (USD MILLION)
TABLE 76. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2027 (USD MILLION)
TABLE 77. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 78. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 79. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2027 (USD MILLION)
TABLE 80. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 81. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 82. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NEPHROLOGY, 2018-2027 (USD MILLION)
TABLE 83. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2027 (USD MILLION)
TABLE 84. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2027 (USD MILLION)
TABLE 85. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD MILLION)
TABLE 86. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2027 (USD MILLION)
TABLE 87. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2027 (USD MILLION)
TABLE 88. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RARE DISEASES, 2018-2027 (USD MILLION)
TABLE 89. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 90. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 91. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2027 (USD MILLION)
TABLE 92. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 93. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 94. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 95. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS (CROS), 2018-2027 (USD MILLION)
TABLE 96. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS (CROS), BY REGION, 2018-2027 (USD MILLION)
TABLE 97. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS (CROS), BY REGION, 2018-2027 (USD MILLION)
TABLE 98. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, 2018-2027 (USD MILLION)
TABLE 99. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 100. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 101. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2027 (USD MILLION)
TABLE 102. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 103. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 104. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 105. AMERICAS CLINICAL TRIAL SUPPLY & LO

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings